Cysteine proteases play key roles in the biology of Plasmodium parasites and are recognized as antimalarial drug targets. Because these enzymes are involved in diverse biological functions, precise regulation is required to prevent unnecessary damage to both parasites and hosts. In this study, we identified an endogenous inhibitor of cysteine protease of Plasmodium vivax (PvICP) and characterized its biochemical properties. PvICP was found to share highly similar structural characteristics with orthologous proteins from other Plasmodium species. Recombinant PvICP (rPvICP) expressed in Escherichia coli showed a broad range of inhibitory activity against falcipain family cysteine proteases, including vivapain-3, vivapain-4, falcipain-3, malapain-2, and malapain-4, with more potent inhibitory activity against vivapain-3 and vivapain-4. rPvICP’s inhibitory activity was not significantly affected by pH, suggesting its broad biological functions. These findings provide new insights into PvICP and lay the groundwork for future studies exploring its biological significance and potential as a therapeutic target in malaria research.
The Trichinella spiralis novel cystatin (TsCstN) inhibits cathepsin L (CatL) activity and inflammation of macrophages during lipopolysaccharide (LPS) induction. To identify the protease inhibitory region, this study applied an in silico modeling approach to simulate truncation sites of TsCstN (Ts01), which created four truncated forms, including TsCstN∆1-39 (Ts02), TsCstN∆1-71 (Ts03), TsCstN∆1-20, ∆73-117 (Ts04), and TsCstN∆1-20, ∆42-117 (Ts05). The superimposition of these truncates modeled with AlphaFold Colab indicated that their structures were more akin to Ts01 than those modeled with I-TASSER. Moreover, Ts04 exhibited the closest resemblance to the structure of Ts01. The recombinant Ts01 (rTs01) and truncated proteins (rTs02, rTs03, and rTs04) were successfully expressed in a prokaryotic expression system while Ts05 was synthesized, with sizes of approximately 14, 12, 8, 10, and 2.5 kDa, respectively. When determining the inhibition of CatL activity, both rTs01 and rTs04 effectively reduced CatL activity in vitro. Thus, the combination of the α1 and L1 regions may be sufficient to inhibit CatL. This study provides comprehensive insights into TsCstN, particularly regarding its protein function and inhibitory domains against CatL.
Citations
Citations to this article as recorded by
Systems biology of Haemonchus contortus – Advancing biotechnology for parasitic nematode control Yuanting Zheng, Neil D. Young, Tao Wang, Bill C.H. Chang, Jiangning Song, Robin B. Gasser Biotechnology Advances.2025; 81: 108567. CrossRef
Therapeutic potentials of Trichinella spiralis in immune disorders: From allergy to autoimmunity Minkyoung Cho, Hak Sun Yu Parasites, Hosts and Diseases.2025; 63(2): 123. CrossRef
The effect of a secretory proteinase from the pathogenic amoebae Acanthamoeba castellanii on host's defense-oriented or regulatory proteins such as immunoglobulins, interleukin-1, and protease inhibitors was investigated. The enzyme was found to degrade secretory immunoglobulin A (sIgA), IgG, and IgM. It also degraded interleukin-1α (IL-1α) and IL-1β. Its activity was not inhibited by endogenous protease inhibitors, such as α2-macroglobulin, α1-trypsin inhibitor, and α2-antiplasmin. Furthermore, the enzyme rapidly degraded those endogenous protease inhibitors as well. The degradation of host's defense-oriented or regulatory proteins by the Acanthamoeba proteinase suggested that the enzyme might be an important virulence factor in the pathogenesis of Acanthamoeba infection.
Citations
Citations to this article as recorded by
A Synthetic View on Acanthamoeba Keratitis Host Immune Response: Potential Factors Influencing the Development of Chronic Inflammation Bianca Prado-Costa, Larissa Fagundes Pinto, Mariana Fernandes Fonseca, Denise de Freitas, Larissa Magalhães Alvarenga Cornea.2025; 44(1): 118. CrossRef
Biological characteristics and pathogenicity of Acanthamoeba Yuehua Wang, Linzhe Jiang, Yitong Zhao, Xiaohong Ju, Le Wang, Liang Jin, Ryan D. Fine, Mingguang Li Frontiers in Microbiology.2023;[Epub] CrossRef
Genetic Background Affects the Mucosal Secretory IgA Levels, Parasite Burden, Lung Inflammation, and Mouse Susceptibility toAscaris suumInfection Luciana Maria Oliveira, Denise Silva Nogueira, Ricardo Marcelo Geraldi, Fernando Sérgio Barbosa, Chiara Cássia Oliveira Amorim, Ana Clara Gazzinelli-Guimarães, Nathália Maria Resende, Natália Pinheiro-Rosa, Lucas Rocha Kraemer, Matheus Silvério Mattos, Li Infection and Immunity.2022;[Epub] CrossRef
Identification and characterization of a secreted M28 aminopeptidase protein in Acanthamoeba Jian-Ming Huang, Yao-Tsung Chang, Min-Hsiu Shih, Wei-Chen Lin, Fu-Chin Huang Parasitology Research.2019; 118(6): 1865. CrossRef
Acanthamoeba Keratitis: Current Status and Urgent Research Priorities Naveed Ahmed Khan, Ayaz Anwar, Ruqaiyyah Siddiqui Current Medicinal Chemistry.2019; 26(30): 5711. CrossRef
Comparison of Proteins Secreted into Extracellular Space of Pathogenic and Non-pathogenic Acanthamoeba castellanii Eun-Kyung Moon, Hyun-Seo Choi, So-Min Park, Hyun-Hee Kong, Fu-Shi Quan The Korean Journal of Parasitology.2018; 56(6): 553. CrossRef
Human antimicrobial peptides in ocular surface defense Imran Mohammed, Dalia G. Said, Harminder S. Dua Progress in Retinal and Eye Research.2017; 61: 1. CrossRef
Evaluation of the immunodiagnostic potential of a recombinant surface protein domain fromAcanthamoeba castellanii ALEMAO G. CARPINTEYRO SÁNCHEZ, VERIDIANA GOMES VIRGINIO, VINICIUS JOSÉ MASCHIO, HENRIQUE BUNSELMEYER FERREIRA, MARILISE BRITTES ROTT Parasitology.2016; 143(12): 1656. CrossRef
An update onAcanthamoebakeratitis: diagnosis, pathogenesis and treatment Jacob Lorenzo-Morales, Naveed A. Khan, Julia Walochnik Parasite.2015; 22: 10. CrossRef
Pathological characteristics of the different stages of Acanthamoeba keratitis Yuzhao Sun, Jing Hong, Pei Zhang, Rongmei Peng, Gege Xiao Histopathology.2013; 63(6): 862. CrossRef
Biology and pathogenesis of Acanthamoeba Ruqaiyyah Siddiqui, Naveed Ahmed Khan Parasites & Vectors.2012;[Epub] CrossRef
Acanthamoeba castellanii: Morphological analysis of the interaction with human cornea Maritza Omaña-Molina, Arturo González-Robles, Lizbeth Iliana Salazar-Villatoro, Ana Ruth Cristóbal-Ramos, Mónica González-Lázaro, Edmundo Salinas-Moreno, Rene Méndez-Cruz, Manuel Sánchez-Cornejo, Enrique De la Torre-González, Adolfo Martínez-Palomo Experimental Parasitology.2010; 126(1): 73. CrossRef
Acanthamoeba culbertsoni
Elicits Soluble Factors That Exert Anti-Microglial Cell Activity
Jenica L. Harrison, Gabriela A. Ferreira, Erinn S. Raborn, Audrey D. Lafrenaye, Francine Marciano-Cabral, Guy A. Cabral Infection and Immunity.2010; 78(9): 4001. CrossRef
Differential effects of α-helical and β-hairpin antimicrobial peptides against Acanthamoeba castellanii R. S. SACRAMENTO, R. M. MARTINS, A. MIRANDA, A. S. S. DOBROFF, S. DAFFRE, A. S. FORONDA, D. DE FREITAS, S. SCHENKMAN Parasitology.2009; 136(8): 813. CrossRef
Detection of a serine proteinase gene in Acanthamoeba genotype T6 (Amoebozoa: Lobosea) Marion Blaschitz, Martina Köhsler, Horst Aspöck, Julia Walochnik Experimental Parasitology.2006; 114(1): 26. CrossRef
Acanthamoeba: biology and increasing importance in human health Naveed Ahmed Khan FEMS Microbiology Reviews.2006; 30(4): 564. CrossRef
Pathogenic free-living amoebae in Korea Ho-Joon Shin, Kyung-il Im The Korean Journal of Parasitology.2004; 42(3): 93. CrossRef
First
Prev
